Search clinical trials for: Dextenza Ophthalmic Insert

Total 2386 results

Marian Macsai, MD

Recruiting

Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy

Fuchs' Endothelial Dystrophy

United States
Tarsus Pharmaceuticals, Inc.

Completed

A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects

Healthy

Canada
Bucci Laser Vision Institute

Withdrawn

Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

Dry Eye

United States
Alcon Research

Terminated

Geographic Atrophy Treatment Evaluation (GATE)

Age-Related Macular Degeneration | Geographic Atrophy
Aerie Pharmaceuticals

Completed

24-hour Efficacy of AR-12286

Ocular Hypertension | Open Angle Glaucoma

United States
Glaukos Corporation

Active, not recruiting

iStent Inject New Enrollment Post-Approval Study

Glaucoma | Glaucoma, Open-Angle

United States
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With DED (STRIDE 3)

Kerato Conjunctivitis Sicca

United States
National Taiwan Normal University

Completed

Effects of Exercise on Energy Intake-Prescription of Resistance Exercise

Eating Behavior | Food Reward

Taiwan
Claris Biotherapeutics, Inc.

Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Neurotrophic Keratitis

United States, Canada
HanAll BioPharma Co., Ltd.

Completed

A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes (VELOS-1)

Dry Eye

United States
PanOptica, Inc.

Completed

Study of Topical Ocular PAN-90806 in PDR

Diabetic Retinopathy

United States
University of Michigan

Completed

Intern Health Study 2021 (IHS 2021)

Telemedicine

United States
University of Michigan

Completed

Intern Health Study: 2020 Cohort Micro-Randomized Trial

Telemedicine

United States
Bayside Health
Baker Heart and Diabetes Institute

Unknown

Eplerenone in the Management of Abdominal Aortic Aneurysms

Aortic Aneurysm, Abdominal

Australia
The Cleveland Clinic

Terminated

Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure (PREDICT)

Diastolic Heart Failure

United States
Laboratorios Sophia S.A de C.V.

Completed

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® (PRO-179/I)

Glaucoma

Mexico
Bausch & Lomb Incorporated

Completed

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Ophthalmic Consultants of Long Island
Pfizer

Completed

Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®

Dry Eye Disease

United States
Benha University

Recruiting

Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking

Corneal Disease

United Arab Emirates
Peregrine Ophthalmic

Completed

POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma

Glaucoma

United States
Laboratorios Poen

Completed

Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost

Primary Open-angle Glaucoma

Argentina
Allergan

Completed

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Canada, United States
Wake Forest University Health Sciences

Not yet recruiting

Post-Operative Cesarean Section Cosmesis

Cesarean Delivery

United States
University of Illinois at Urbana-Champaign
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern... and other collaborators

Not yet recruiting

Virtual Reality in Hemodialysis to Improve Psychological Well-being

Depressive Symptoms | End Stage Kidney Disease
Glaukos Corporation

Recruiting

Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Grene Vision Group
Ocular Therapeutix, Inc.

Completed

The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1

Cataract

United States
JeniVision, Inc.

Suspended

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Aramis Biosciences, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Jonsson Comprehensive Cancer Center

Withdrawn

Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants

Breast Cancer | Alopecia

United States
PanOptica, Inc.

Completed

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Neovascular Age-related Macular Degeneration

United States, Czechia, United Kingdom, Hungary, Latvia
Optimal Health Research

Completed

Treating Post-Lyme Disease Syndrome With Acetogenins

Post-Lyme Disease Syndrome (PLDS)

United States
Aldeyra Therapeutics, Inc.

Completed

A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

Dry Eye

United States
Alcon Research

Completed

Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Glaucoma
University of Edinburgh

Not yet recruiting

Diagnosing Corneal Infection

Corneal Ulcer (Diagnosis)
AstraZeneca

Completed

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Alcon Research

Completed

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
University of Miami

Completed

Suture Contamination Rate in Adjustable Suture Strabismus Surgery

Suture Strabismus Surgery

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

Genetic Diagnosis in Congenital Cataracts

Congenital Cataract

China
Essilor International
Elite School of Optometry and Sankara Nethralaya

Completed

Objective and Subjective Evaluation of Ophthalmic Lenses With Extra Power

Asthenopia
MicroPort Orthopedics Inc.

Recruiting

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Joint Diseases

Italy
EyePoint Pharmaceuticals, Inc.

Completed

Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma

Primary Open Angle Glaucoma | Ocular Hypertension

United States
Silk Technologies, Ltd.

Completed

Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)

Dry Eye

United States
M.D. Anderson Cancer Center

Terminated

Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma

Retinoblastoma

United States
National Taiwan University Hospital

Completed

PET on Surgery for Loco-regionally Recurrent Colorectal Cancer

PET-driven Surgery | Loco-regional Recurrent Colorectal Cancer

Taiwan
Santen Pharmaceutical Co., Ltd.

Completed

A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT

Open Angle Glaucoma or Ocular Hypertension

Singapore
Allergan

Completed

A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

Presbyopia

United States
Alcon Research

Completed

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

Ocular Hypertension | Glaucoma | Open-Angle Glaucoma
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome (PRO-148)

Dry Eye Syndrome

Mexico
Allergan

Completed

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

United States

3

Subscribe